Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 16-30 of 62 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Alessandra RossiView profile

Assistant Professor

University of ParmaItaly

Dr. Alessandra Rossi is an Assistant Professor at the Faculty of Pharmacy, University of Parma, specializing in drug delivery systems and pharmaceutical technology. Her research focuses on polymorphism of drugs, drug-excipient interactions, oral/nasal/pulmonary delivery systems, and nano/microparticle characterization. PhD in Pure and Applied Chemistry (University of Strathclyde, 1998) Erasmus/Socrates Research Fellowship (University of Gent, 1993-1994) Novartis Pharma AG Research Fellowship (Heriot-Watt University, 1998) Key research areas include: Development of oral hydrophilic matrices for controlled drug release Characterization of nasal and pulmonary delivery systems for targeted therapies Microencapsulation and agglomeration techniques for improved bioavailability Design of dry powder inhalers and heart-targeting nanoparticle systems Application of Quality by Design in pharmaceutical development Recent publications highlight her work in Acai oil-based organogels for topical cosmetics Microparticle systems for lung-targeted antioxidants Ligand-functionalized nanocarriers for liver cancer therapy Optimization of dry powder inhalation technologies Scientific awards and fellowships: Erasmus/Socrates Research Fellowship (1993-1994) Novartis Pharma AG Fellowship (1998)

Official University Profile

Mohammad M. SajadiView profile

Professor

University of Maryland, BaltimoreUnited States

Mohammad M. Sajadi, MD, is Professor of Medicine and Associate Professor of Medicine in the Division of Clinical Care and Research at the Institute of Human Virology, University of Maryland School of Medicine. Based in Baltimore, he directs a translational research program focused on HIV-1 humoral immunity and SARS-CoV-2 immunology. Education & Training: While the provided text does not list explicit degrees, his MD title indicates medical training followed by specialty and research training in infectious diseases and virology. Research Interests: Dr. Sajadi’s laboratory studies the molecular basis of broadly neutralizing antibody responses against HIV-1, with particular attention to elite controllers who suppress virus without therapy. The group engineers next-generation monoclonal antibodies for improved potency, manufacturability, and CNS delivery. Parallel efforts dissect SARS-CoV-2 immunity, exploring antibody durability, mucosal protection, and environmental influences on COVID-19 mortality. Publication Trends: Across >50 recent papers, a clear trajectory emerges: early work defined signatures of broad HIV neutralization in plasma, followed by mechanistic studies on λ-light-chain bias and memory B-cell responses. Recent outputs pivot toward translational development—liposomal antibody delivery, glial progenitor-based gene therapy for HIV brain reservoirs, and multiplex serology platforms. COVID-19 studies mirror this translational depth, covering vaccine immunogenicity, maternal antibody transfer, and climate-linked epidemiology. Scientific Recognition: While no specific awards are listed, sustained NIH and institutional funding, high-impact publications in J Infect Dis , J Virol , PNAS , and invited reviews in 2020-2025 collectively underscore international recognition in HIV and COVID-19 antibody research. Grants & Collaborations: Dr. Sajadi leads multi-disciplinary teams spanning virology, structural biology, and pharmacology. Active collaborations include the NIAID-funded Consortia for HIV/AIDS Vaccine Development, the Global COVID-19 Convalescent Plasma Project, and industry partnerships for antibody manufacturing scale-up. Laboratory & Teams: The Sajadi Laboratory is housed within the Institute of Human Virology, occupying state-of-the-art BSL-2/3 space. Core teams include post-doctoral fellows, graduate students, research technicians, and computational biologists working on antibody engineering, single-cell B-cell repertoire analysis, and in vivo challenge models.

Official University Profile

Ion SMARANDAView profile

Researcher

National Institute of Materials PhysicsRomania

Dr. Eng. Ion SMARANDA is a Scientific Researcher III at the National Institute of Materials Physics Măgurele, working in the Optical Processes in Nanostructured Materials Laboratory. He has been with the institute since 2010, progressing from Research Assistant (2010-2018) to Scientific Researcher (2018-2023) and currently Scientific Researcher III (2023-present). His educational background includes: PhD in Physics (2013-2018) from the Faculty of Physics, University of Bucharest, Department of Optics, Spectroscopy, Plasma, Lasers Master Degree in Optics, Spectroscopy, Plasma and Laser (2009-2011) from University of Bucharest, Faculty of Physics, Department of Physics Engineer's Degree in Technological Physics (2004-2009) from University of Bucharest, Faculty of Physics Dr. SMARANDA's research focuses on the optical, structural, and electrical properties of nanomaterials and composites . His work spans multiple disciplines including materials science, nanotechnology, and pharmaceutical photodegradation studies. He employs a wide range of spectroscopic techniques including photoluminescence, UV-VIS-NIR absorption spectroscopy, Raman scattering, FT-IR spectroscopy, dielectric spectroscopy, and cyclic voltammetry . A significant portion of his research involves 2D materials like WS 2 and MoS 2 , conductive polymers such as poly(ortho-toluidine), and their composite applications in supercapacitors and other electronic devices. His recent publications demonstrate a strong trend toward 2D material synthesis and characterization , particularly monolayer WS 2 production at low temperatures for electronic applications. He also maintains an active research line in pharmaceutical photodegradation , studying how drugs like azathioprine, losartan, and pantoprazole degrade under light exposure. His work bridges fundamental materials science with practical applications in energy storage and pharmaceutical stability. Dr. SMARANDA has developed expertise in multiple advanced characterization techniques and has contributed to novel synthesis methods for nanomaterials and composites. His collaborative approach is evident in his numerous co-authored publications across various high-impact journals. He works within the Optical Processes in Nanostructured Materials Laboratory at the National Institute of Materials Physics, where he conducts research on advanced materials characterization and development.

Official University Profile

Richard GuyView profile

Professor

University of MiskolcHungary

Richard Guy is a Professor in the Department of Life Sciences at the University of Bath, with extensive affiliations across interdisciplinary research centres, including the Centre for Sustainable Chemical Technologies (CSCT), Centre for Nanoscience and Nanotechnology, Centre for Therapeutic Innovation, Centre for Mathematical Biology, and Centre for Bioengineering & Biomedical Technologies (CBio). He maintains an active research profile with a substantial publication record and leadership in major research projects. His research focuses on transdermal and topical drug delivery , with particular expertise in dermatopharmacokinetics, iontophoresis, reverse iontophoresis, and the bioequivalence of topical formulations . He investigates how drugs penetrate and are cleared from the skin, utilizing advanced techniques such as Raman spectroscopy, mass spectrometry imaging, and reverse iontophoresis for non-invasive monitoring. His work also explores the use of nanoparticles, film-forming systems, and laser ablation to enhance drug delivery. Analysis of his recent publications (2023–2025) reveals a strong trend in non-invasive and imaging-based methodologies for visualizing and quantifying drug distribution in skin. His work integrates analytical chemistry (Raman, mass spectrometry) with pharmaceutical formulation science to solve problems in dermatology and transdermal delivery . There is a consistent theme of method development for assessing bioavailability and bioequivalence, often applied to corticosteroids and other dermatological agents. Prize (1) Professor Guy has supervised 18 research students and leads 22 research projects, indicating a significant role in academic mentoring and grant-funded research. His work often involves collaboration with industrial and clinical partners, particularly in the development of diagnostic devices and regulatory science initiatives. He has contributed to policy discussions on regulatory science in Europe. He is a key member of several research centres at Bath, fostering a collaborative environment that bridges chemistry, engineering, biology, and medicine for the development of innovative drug delivery technologies and diagnostic tools.

Official University Profile

Krum KafedjiiskiView profile

Associate Professor

Medical University - PlevenBulgaria

Krum Kafedjiiski is an Associate Professor at the Department of Pharmaceutical Sciences and Social Pharmacy within the Faculty of Pharmacy at the Medical University of Pleven . His work focuses on pharmaceutical formulation and advanced drug delivery systems.

Official University Profile

Núria Oliva JorgeView profile

Assistant Professor

University of CincinnatiUnited States

Núria Oliva Jorge, PhD, is an Assistant Professor at the Department of Bioengineering, IQS School of Engineering, Institut Químic de Sarrià (Universitat Ramon Llull). She is a faculty member in the Master’s Degree in Materials Science and Engineering and contributes to programs in Biotechnology, Biomedical Sciences, and Cosmetics. Her academic role is supported by the prestigious Junior Leader F. La Caixa program, emphasizing her leadership in translational research. Her research interests focus on biomaterials , nanotechnology for cancer therapy , bioadhesives , and cartilage regeneration . She is a key member of the GEMAT – Materials Engineering research group, where she leads projects at the intersection of materials science and regenerative medicine. The recent publications and projects reflect a strong trend in developing injectable, biocompatible, and smart biomaterials for therapeutic applications, particularly in osteoarthritis , diabetic foot ulcers , and drug-free wound healing . Her work integrates nanotechnology-enabled gene therapy and targeted molecular delivery , showcasing a multidisciplinary approach to unmet clinical needs. Her scientific recognition includes the Junior Leader F. La Caixa award, which supports her innovative research program. She actively supervises master’s theses and mentors students in advanced research projects. She is involved in advising and project leadership, particularly in externally funded initiatives such as REJUVEN8, APTADEGRAD, Biomaterials Osteoarthritis, and HYDROMIRNA. These projects involve collaboration with industry and research centers, reflecting her commitment to translational science and technology transfer. The GEMAT research group provides a collaborative environment for developing functional materials, surface engineering, and biomaterials. The lab infrastructure at IQS, with over 8,700 m² of advanced laboratories, enables high-level experimental work in materials synthesis, characterization, and application testing.

Official University Profile

Urve PaaverView profile

Associate Professor

University of TartuEstonia

Dr. Urve Paaver is a full-time Associate Professor of Pharmaceutical Technology and Program Manager of Continuing Education at the Department of Pharmacy, University of Tartu, Faculty of Medicine. His career spans over four decades, including a diploma in pharmacy (1981), an MSc in organic chemistry (2006), and a PhD in pharmacy (2015) from the University of Tartu. His research focuses on multifunctional nanomedicines , solid pharmaceuticals , and 3D printing technologies for drug delivery. He leads the continuing education program at the Institute of Pharmacy and teaches courses on pharmaceutical excipients and technology. His work explores the physical stabilization of poorly water-soluble drugs, dissolution behavior, and excipient functionality in formulations. Dr. Paaver has participated in numerous research projects, including VMVFA22189: Development of 3D-printed drugs with process analytical technology (2022–2025) Multifunctional nanomedicines (2015–2020) Development of honey-based ointments/gels (2018) He has authored over 130 publications, edited textbooks, and reviewed for journals like the Journal of Pharmacy and Pharmacology . His accolades include: 2021 Silver Award, International DDRS Conference 2020 Estonian Academic Pharmaceutical Society recognition 2018 University of Tartu Medal of Honor 2017 Best Lecturer of the Year in Pharmacy Dr. Paaver is active in Prof. J. Heinämäki’s research group and contributes to advancements in nanofibrous drug delivery systems and tablet coating technologies.

Official University Profile

Mirela-Andreea PARASCHIVView profile

Researcher

National Institute of Materials PhysicsRomania

Mirela-Andreea PARASCHIV serves as an Assistant Researcher at the Laboratory of Optical Processes in Nanostructured Materials within the National Institute of Materials Physics in Măgurele, Romania. Her research bridges pharmaceutical stability analysis and advanced nanomaterials development through sophisticated optical characterization techniques. Education Licentiate in Biophysics (2015-2018), University of Bucharest, Faculty of Physics Master in Medical Physics (2018-2020), University of Bucharest, Faculty of Physics Doctoral Candidate since 2021, Doctoral School of Physics, University of Bucharest (Optics, Spectroscopy, Plasma and Lasers) Research Expertise Dr. PARASCHIV specializes in comprehensive optical characterization including UV-vis spectroscopy, FTIR absorption, Raman scattering, and photoluminescence analysis. Her methodological expertise spans nanocomposite synthesis, centrifugation techniques, and experimental data interpretation. She has developed novel approaches for analyzing pharmaceutical photodegradation pathways and polymer-nanomaterial interactions. Publication Trends Her recent publications demonstrate dual research trajectories: pharmaceutical photostability studies examining nifedipine, ampicillin, pantoprazole, and losartan through multimodal spectroscopy; and advanced nanomaterials research focusing on polymer-TiO 2 , polyurethane-WS 2 , and polystyrene-graphene oxide composites. These works consistently employ correlated spectroscopic techniques to reveal molecular-level degradation mechanisms and structure-property relationships. Scientific Contributions Dr. PARASCHIV co-holds a patent for thermoplastic polyurethane-TiO 2 nanoparticle composite synthesis. Her collaborative research extends across multiple Romanian institutions including the University of Bucharest and INCDFM, with significant contributions to understanding nanomaterial-polymer interfaces and pharmaceutical degradation kinetics. Laboratory Work At the Laboratory of Optical Processes in Nanostructured Materials, she leads experimental investigations using advanced spectroscopic equipment to characterize novel composite materials. Her work integrates wet chemical synthesis with comprehensive optical analysis to develop materials with tailored properties for energy storage, pharmaceutical applications, and functional coatings.

Official University Profile

Jette JacobsenView profile

Associate Professor

University of CopenhagenDenmark

Jette Jacobsen serves as an Associate Professor in the Department of Pharmacy within the Faculty of Health and Medical Sciences at the University of Copenhagen, specializing in Physiological Pharmaceutics. Her research focuses on developing advanced drug delivery systems for oral mucosal administration, with particular emphasis on understanding absorption barriers and creating biorelevant testing methods. PhD (pharm.), University of Copenhagen, 1995 MSc (pharm.), University of Copenhagen, 1990 Apoteksassistent, 1986 Professor Jacobsen's research program centers on oromucosal drug delivery systems, with three primary thrusts: (1) mechanistic understanding of bioadhesion, drug release, and absorption processes; (2) development of biorelevant in vitro methods including cell culture and modified Ussing chamber techniques for studying drug permeability and toxicity; and (3) formulation of aqueous gels for treating mucosal disorders. Her work bridges fundamental science with practical applications in pharmaceutical development. Analysis of her recent publications reveals consistent focus on buccal and gastrointestinal drug delivery systems, with increasing emphasis on biorelevant testing methods and physiological barriers. Her research spans from fundamental studies of mucus properties to applied formulation development for peptide delivery and ocular therapeutics. The interdisciplinary nature of her work connects pharmaceutical technology with physiology, biochemistry, and clinical applications. Professor Jacobsen has maintained continuous academic employment since 1995, progressing from PhD student to her current position as Associate Professor. She has supervised numerous research projects and contributed to educational materials in pharmacy, including co-editing the 5th edition of 'Almen Farmaci.' Her research collaborations span multiple departments and institutions, reflecting the interdisciplinary nature of her work in physiological pharmaceutics.

Official University Profile

Erika FERRARIView profile

Associate Professor

University of Modena and Reggio EmiliaItaly

Erika Ferrari is an Associate Professor at the Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia. Her research focuses on inorganic medicinal chemistry , particularly in metal-based drug development , metal trafficking studies , and advanced NMR techniques for complex matrices. She leads projects on inorganic drug delivery systems and theranostic agents , with significant work on curcumin derivatives and bioactive glasses. Current projects include development of 68Ga-labeled radiotracers for Alzheimer's and cancer imaging Environmental applications in soil organic matter analysis and microalgae-based biostimulants Research Highlights: Her work bridges coordination chemistry with pharmaceutical applications , focusing on metal chelation therapy , anticancer agents , and green synthesis methods . Recent publications emphasize mesoporous silica carriers and stabilized curcumin analogs . Teaching: She instructs courses in General and Inorganic Chemistry , Industrial Inorganic Chemistry , and Coordination Compound Chemistry , emphasizing stoichiometry , chemical equilibria , and laboratory safety .

Official University Profile

Mauro BancheroView profile

Associate Professor

Polytechnic University of TurinItaly

Mauro Banchero is an Associate Professor at the Department of Applied Science and Technology (DISAT) , Polytechnic University of Turin , and a key member of the SMAC (Supercritical Fluids and Materials Chemistry) research group. His academic journey began with a Chemical Engineering degree (1995) and a PhD in Chemical Engineering (1998) . Research Interests span supercritical fluid applications in pharmaceuticals, food technology, and materials science , with emphasis on phase equilibria, thermodynamic modeling , and process intensification . His work includes reactor design , supercritical extraction , and innovative biodiesel production from renewable sources. Recent Publications highlight advancements in supercritical CO2-based drug delivery , hybrid silica-cyclodextrin materials , and hemostatic medical devices . These studies align with UN SDG 3 (Good Health) and SDG 9 (Innovation) . Society of Dyers and Colourists Centenary Medal (2013, 2020) National Scientific Qualification (MIUR, Italy, 2013) Teaching Roles include courses on Multiphase Chemical Reactors and Food Packaging Technologies for the Chemical and Sustainable Process Engineering program since 2019. He also contributes to doctoral colleges and academic governance. Laboratory Affiliations include the Supercritical Fluids Laboratory and Nanoporous Materials Laboratory , where he develops experimental apparatuses and conducts applied research.

Official University Profile

Sandrine GerberView profile

Adjunct Professor

Swiss Federal Institute of Technology in LausanneSwitzerland

Dr. Sandrine Gerber is an Adjunct Professor at the École Polytechnique Fédérale de Lausanne (EPFL) in the School of Basic Sciences and Deputy Director of the Institute of Chemical Sciences and Engineering. She leads research in biomaterials engineering and nanomedicine, with particular focus on functionalized polymers for therapeutic applications. Her laboratory develops alginate-based hydrogels for cell transplantation and functionalized nanoparticles for targeted drug/gene delivery. Research domains include: Design of polysaccharide-based hydrogels for islet/hepatocyte transplantation Surface modification of harmonic nanoparticles for cancer theranostics Chitosan copolymers for gene delivery in metabolic diseases Functional biomaterials for tissue engineering scaffolds Her publication portfolio demonstrates strong emphasis on nanomaterial functionalization strategies, with recent work focusing on biosensor interfaces, lithium niobate nanoparticles for imaging, and COVID-19 therapeutic formulations. She serves on committees for the Doctoral Program in Chemistry and Chemical Engineering and contributes to EPFL's educational programs in organic chemistry. Scientific honors include the Werner Prize (2010) and Excellence in Teaching Award (2018). She has supervised 15+ PhD candidates and numerous master's students in biomaterials and synthetic chemistry.

Official University Profile

James WarwickerView profile

Associate Professor

The University of ManchesterUnited Kingdom

James Warwicker is a Reader (equivalent to Associate Professor) in the Division of Molecular and Cellular Function at the University of Manchester's Faculty of Biology, Medicine and Health. He directs the MSc in Bioinformatics and Systems Biology and leads the Warwicker Research Group at the Manchester Institute of Biotechnology. His research focuses on developing theoretical methods to analyze biological molecules using physics and chemistry principles. Warwicker's education includes a Physics degree (1979) and PhD in Biochemistry (1983) from the University of Bristol, followed by postdoctoral work at Yale University (1983-1988). His research interests span structural bioinformatics, macromolecular modelling, protein solubility prediction, enzyme catalysis mechanisms, and pH-dependent protein properties. His group develops computational tools to study charge-charge interactions, protein stability, and molecular recognition in biological systems. His recent publications demonstrate a focus on computational investigation of pH-dependent mechanisms in biological systems, including viral envelopes, ion channels, and protein formulations. Research consistently integrates biophysical modeling with experimental validations. Warwicker currently supervises multiple PhD students and research associates. His group maintains active collaborations with theoretical and experimental teams internationally. Current projects include developing models for predicting pH-dependence in host-pathogen systems and protein solubility prediction tools. Major funding sources include BBSRC, Wellcome Trust, and UKIERI. The Warwicker Lab develops web-based tools for protein analysis, including protein solubility prediction servers and computational resources for studying electrostatic properties. The group is part of the Manchester Institute of Biotechnology's structural biology research community.

Official University Profile

ROSSI AlessandraView profile

Associate Professor

University of ParmaItaly

Alessandra Rossi is an Associate Professor at the Department of Food and Pharmaceutical Sciences, University of Parma. She coordinates the department's International Mobility Commission and contributes to the university's Internationalization Working Group. Her academic journey includes a PhD at the University of Strathclyde and postdoctoral work at Heriot-Watt University. PhD in Pure and Applied Chemistry (1998, University of Strathclyde) Graduated in Chemistry (1993, University of Pavia) Her research focuses on pharmaceutical technologies for controlled drug release, including hydrophilic matrices, nasal/pulmonary powders, and nano-microparticulate systems. She leads the COST Action SimInhale's Working Group 1 on particle engineering for inhaled medicines. Key trends in her publications include 3D-printed drug forms , phytoextract microencapsulation , nano-inhalation systems , and biopharmaceutical modeling . Her work bridges formulation science with clinical applications. Erasmus Scholarship (1993) Novartis Postdoctoral Fellowship (1998) She mentors students through teaching roles in Pharmaceutical Legislation, Galenic Preparations, and bibliographic research, with ongoing involvement in multidisciplinary pharmaceutical projects.

Official University Profile

Kathy GiacominiView profile

Professor

University of California, San FranciscoUnited States

Kathy Giacomini is a Professor and Dean of the University of California San Francisco (UCSF) School of Pharmacy. She holds joint appointments in the Department of Cellular and Molecular Pharmacology (School of Medicine) and the Department of Pharmaceutical Chemistry . Her leadership focuses on advancing the School’s mission in research, education, and patient care, particularly in precision medicine and pharmacogenomics. Dr. Giacomini’s research centers on membrane transporter biology , including SLC22 family members like OCT1 and OCT3. Her work explores how genetic variation in transporters affects drug disposition and response, especially in anti-diabetic medications such as metformin and sulfonylureas. She co-leads the UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation (CERSI) , the first FDA-funded CERSI on the U.S. West Coast. Her recent publications highlight advances in transporter-mediated drug interactions, pharmacogenetic testing, and the role of excipients in drug absorption. Key research areas include metformin pharmacogenetics , transporter structural determinants , and precision medicine applications for ethnically diverse populations. Scientific Awards include election to the American Academy of Arts and Sciences (2024), Reynold Spector Award (2023), Volwiler Research Achievement Award (2018), and National Academy of Medicine membership (2006). She advocates for Diversity, Equity, and Inclusion , establishing the CERSI Diversity Scholars Program and promoting underrepresented minorities in pharmacogenomics and pharmaceutical sciences. Dr. Giacomini’s laboratory collaborates extensively with institutions like Stanford University and the Quantitative Biosciences Institute, advancing understanding of transporter proteins as therapeutic targets and determinants of drug safety.

Official University Profile